Трибестан

Quick links

Choose a section

Quick links to important sections

Advertisements

Трибестан

Selected form

Advertisements
Advertisements

Overview of Трибестан

Property Description
Active Ingredient Tribuli Terrestris Herbae Extract
Form Film-coated tablet
Pharmacological Class Phytopreparation (G04BX)
General Purpose Support for sexual system function and general tonic effect
Origin Agent of vegetable origin

What Type of Medicine is Трибестан and What is its Origin?

Трибестан is a registered medicinal product classified as a phytopreparation or an Agent of vegetable origin. This preparation is administered via the oral route in the form of a film-coated tablet. It is classified within the anatomical-therapeutic-chemical (ATC) system under the group G04BX (Other Urological Preparations), a placement which reflects its pharmacological relationship to the genitourinary system. The preparation is manufactured by Sopharma AD, lending a specific manufacturing source to this particular composition, which is licensed for use as part of therapeutic regimens aimed at addressing certain functions of the sexual system.

Compositional Identity: The Standardized Tribulus Terrestris Extract

The sole active ingredient is the Tribuli Terrestris Herbae Extract (сухой экстракт травы якорцев стелющихся). This preparation is distinguished by being a standardized extract, which is critical for consistency, ensuring that the concentration of the active chemical components, primarily the Furostanol Saponins, is reliably uniform. The key constituent, Protodioscin, is the marker compound for this standardization process. Studies examining the biological actions of these compounds note their systemic influence on physiological processes related to vitality.

General Purpose and Physiological Support

The general purpose of Трибестан is defined by its pharmacological classification as a Potency stimulator of vegetable origin and its documented ability to confer a hypolipidemic effect. The preparation is intended to contribute to the body’s overall physiological balance by providing a general tonic effect and supporting the functional capacity of the sexual system. This broad mechanism of support positions it as a supportive agent for maintaining general well-being and function.

Regulatory References

  1. Registers - Bulgarian Drug Agency
Advertisements

What side effects are possible with Трибестан?

Possible Side Effects and Safety Information

The active component of Трибестан is an extract of Tribulus terrestris, and its safety profile is primarily characterized by generally mild and uncommon side effects with short-term use.

Commonly Reported Adverse Reactions

Adverse reactions are usually reported as mild and infrequent (uncommon), primarily affecting the gastrointestinal system. These reactions may include:

  • Stomach discomfort or pain
  • Cramping
  • Diarrhea

Serious and Clinically Significant Adverse Reactions

Although the product is generally considered possibly safe for short-term use, severe reactions have been documented in isolated case reports, often linked to high doses or chronic use of the supplement:

  • Reports of liver and kidney damage (nephrotoxicity), including acute kidney injury.
  • Serious lung problems have been linked to ingesting the spine-covered fruit of the plant, which is considered unsafe.
  • The product may affect blood sugar and blood pressure control.

Population-Specific Safety Considerations

Population Safety Note Restriction
Pregnancy Considered possibly unsafe based on animal research suggesting potential harm to fetal development. Avoid use.
Breast-feeding Insufficient reliable information is available to confirm safety. Avoid use.
Pre-Surgical May affect blood sugar and blood pressure, potentially interfering with surgical control. Discontinue at least two weeks prior to scheduled surgery.

Safety-Related Restrictions and Interactions

Caution is advised when using this product concurrently with certain medications due to the potential for additive effects:

  • Antidiabetes Drugs: May cause blood sugar levels to drop too low.
  • Antihypertensive Drugs: May cause blood pressure to drop too low.
  • Lithium: The product may act as a diuretic, potentially increasing lithium concentrations and leading to serious side effects.

The long-term safety of using the extract for periods exceeding 90 days is not established in regulatory or authoritative literature. Consult a healthcare professional regarding all known medical conditions and concurrent medications before use.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help


Documented Overdose Profile

The official regulatory guidance for an overdose of Трибестан (Tribuli Terrestris Herbae Extract) indicates that the clinical presentation is generally non-specific. Manifestations are expected to be an exaggeration of known adverse effects, primarily involving the gastrointestinal system and associated discomfort. Due to the limited clinical data on acute overdose of this phytopreparation, specific severe or life-threatening outcomes are not formally documented in the official prescribing information. The regulatory guidance also notes that no explicit population-specific considerations are detailed in the general overdose section for individuals with conditions such as hepatic or renal impairment.


Required Emergency Action and Management

In the event of a suspected overdose or accidental ingestion of an excessive quantity of the medicinal product, immediate medical attention must be sought as the mandated emergency action. The regulatory classification explicitly confirms that no specific antidote is known for Tribuli Terrestris Herbae Extract. Therefore, the established treatment protocol dictates that management must be symptomatic and supportive, requiring subsequent clinical observation and monitoring under professional care. This structured approach, based on the official label, emphasizes urgent professional assessment and the management of symptoms, given the constraints of the product's known overdose profile.

Advertisements

Therapeutic Uses of Трибестан

Трибестан is a phytopreparation applied across therapeutic domains where symptoms create noticeable interference with functional stability and overall patient comfort. It is used in situations involving certain distressing symptoms related to sexual health, reproductive function, and general systemic support. The plant extract that forms the basis of the medication, Tribulus terrestris, is traditionally used in Ayurveda as a Vrsya (aphrodisiac) for men, which aligns with its primary therapeutic application.

The preparation may be applied in conditions characterized by symptoms that interfere with daily functioning, such as diminished sexual desire, mild to moderate functional erectile dysfunction, and elevated blood lipids.

“It is commonly used when short-term symptomatic assistance is needed to help manage distressing symptoms of low vitality and sexual function.”

This medication helps address symptom clusters related to functional sexual deficits and metabolic imbalances. It is commonly used when symptoms become more noticeable, offering supportive relief that helps patients cope more steadily during symptomatic periods.

Quick Fact: Relief for Low Libido The medication is relevant for easing symptoms of low sexual desire and may assist with supportive benefit for symptom patterns associated with sexual dissatisfaction in both men and women.

Regulatory References

  1. traditionally used in Ayurveda as a Vrsya (aphrodisiac) for men
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use Трибестан

Official regulatory documents define the eligible population for Трибестан by establishing specific age limits and formal contraindications based on existing medical conditions and physiological states. Use of the medicine is established only for Adults 18 years and older.

Absolute Contraindications (Must Not Use)

The medicine is formally contraindicated, meaning its use is strictly prohibited, in the following populations and conditions:

  • Patients with known hypersensitivity or allergy to the active substance (Tribulus terrestris extract) or any component.
  • Individuals diagnosed with androgen-sensitive tumours.
  • Patients with pre-existing liver diseases or liver deficiency.
  • Patients with hypotension (low blood pressure).

Restrictions and Limitations

Use is not recommended in several populations due to insufficient or unestablished safety data in those groups:

  • Children and Adolescents under 18 years.
  • Women who are pregnant or breastfeeding.

Additionally, patients using this product should be advised to avoid excessive sun exposure due to the possibility of phototoxic reactions.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Regulatory Information for Трибестан

This section outlines the formally documented interaction profile of Трибестан based strictly on the final regulatory prescribing information available from governmental health authorities (e.g., EMA, FDA-aligned labels).

Category Official Regulatory Status
Medicinal product categories with documented interactions None explicitly listed in the citable final regulatory prescribing information.
Specific interacting medicines None explicitly listed in the citable final regulatory prescribing information.
Mechanistic basis of interactions No specific pharmacokinetic or pharmacodynamic mechanisms are formally documented in the citable final regulatory prescribing information.
Interaction-related restrictions No formal contraindications, prohibitions, or mandatory dose-timing separations based on interaction risk are explicitly required by the citable regulatory prescribing information.

Official interaction statements:

  • The official government regulatory prescribing information for Трибестан does not include explicit statements detailing mandatory restrictions or prohibitions related to drug-drug or drug-substance interactions.
  • The regulatory label does not formally document any pharmacokinetic interaction patterns, such as CYP-enzyme or transporter effects, that necessitate dose adjustment or timing separation.
  • No specific medicinal product or substance is classified as contraindicated for co-administration due to an officially documented pharmacodynamic or pharmacokinetic interaction risk.

Connection to the overall interaction profile:

The official interaction structure is defined by the absence of specific, citable statements regarding interacting substances, mechanistic pathways, or mandatory restrictions in the final regulatory prescribing label. Consequently, the regulatory documentation does not define formal constraints on co-administration with other medicinal products, foods, or herbal products.

Advertisements

Mechanism of Action

Трибестан, a preparation derived from Tribulus terrestris, contains furostanol steroidal saponins, notably protodioscin, as the primary bioactive constituents. These saponins are absorbed and metabolized, with proposed molecular targets influencing the neuroendocrine system and peripheral vascular tissues.

Neuroendocrine Modulation

Protodioscin is structurally analogous to precursors of dehydroepiandrosterone (DHEA). The presence of these metabolites is hypothesized to modulate the hypothalamic-pituitary-gonadal (HPG) axis. Specifically, studies suggest an interaction that results in the secretion of luteinizing hormone (LH) from the pituitary gland. This LH surge acts on Leydig cells in the testes, stimulating androgen biosynthesis and release. Some data also propose an action via the follicle-stimulating hormone (FSH)-linked pathway.

System-Level Effects

In peripheral tissues, the extract contributes to vasodilation in the corpus cavernosum via the nitric oxide (NO)/nitric oxide synthase (NOS) pathway. The steroidal saponins promote the release of nitric oxide (NO) from the endothelium and nerve endings, leading to the intracellular accumulation of cyclic guanosine monophosphate (cGMP). The subsequent cGMP-mediated relaxation of vascular smooth muscle causes increased tissue perfusion, a system-level physiological consequence.

Advertisements

Dosage and Administration Information

How to Use Трибестан

The administration of Трибестан is determined by standardized usage patterns. This preparation is classified for oral use in the form of a film-coated tablet containing 250 mg of the Tribulus Terrestris dry extract. The administration route requires that the tablet be swallowed whole with water and should not be crushed or chewed.

Dosing and Frequency Patterns

The typical regimen involves a divided daily dose, often taken three times a day (t.i.d.). Standard therapeutic doses range from one to two tablets per dose, resulting in a total daily intake that typically reaches 750 mg of the extract, though the maximum labeled daily dose may be up to 1500 mg. The tablets should be taken with meals or immediately after a meal, which defines the appropriate timing for intake throughout the day.

Course Duration and Cycles

Use of the medication is often structured into defined time courses or cycles. For certain applications, the course may last for a minimum of 90 days. In female patients with specific endocrine conditions, administration follows a cyclic pattern that is synchronized with the menstrual cycle, such as administration from day 1 to day 12 of the cycle. For continued use, a reduction to a maintenance dose (e.g., two tablets daily) may be followed for extended periods. The preparation is indicated only for persons 16 years of age and older, restricting its use in pediatric populations.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of Studies for Трибестан

This overview summarizes the available research regarding the clinical evaluation of Трибестан, focusing on study design, populations, and measured outcomes, as reported in scientific literature and clinical registers. This text does not provide clinical advice or treatment recommendations.


Research Evidence for Male Sexual Function

Clinical evidence for this preparation includes short-term Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies were primarily applied in trials assessing short-term or episodic symptom patterns in adult men with conditions marked by functional limitations, such as mild to moderate erectile dysfunction and low sexual desire. Researchers monitored patient-reported outcomes using validated functional scales (e.g., IIEF), and also monitored serum hormone levels. The research so far indicates findings were mixed regarding changes in hormone levels.


Research Evidence for Female Sexual Function

The preparation was studied for its application in women experiencing symptoms of low sexual desire, primarily using short-term RCTs. These trials research examined outcomes using validated female functional scales (e.g., FSFI). The available evidence base is noted to be heterogeneous (variable), which contributes to a very low level of evidence certainty.


Research on Metabolic Markers

The preparation was studied for its potential association with outcomes related to systemic or functional imbalance, such as the serum lipid profile. Research for this largely consists of Systematic Reviews. However, the evidence is limited because these outcomes were frequently collected as secondary endpoints in studies originally focusing on other health areas.


Long-Term Outcomes and Follow-up Data

Across all studied conditions, research exploring short-term symptom changes is the dominant pattern, with follow-up durations limited (1 to 4 months). Consequently, there is limited information for long-term outcomes and stability. Furthermore, data for certain groups remain insufficient, and the results apply only to the populations studied (adult men and women of reproductive age).


What Is Still Uncertain About the Research

A major limitation is that evidence quality varies across studies, making the certainty low overall. The outcomes indicate findings were mixed, and comparative evidence is lacking to fully contextualize the preparation. The available studies help show what has been observed so far, but provide context rather than individual predictions.

Key Studies & References

  1. Tribulus terrestris does not increase serum testosterone and improves sexual function in males: a systematic review and meta-analysis
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Трибестан (FAQ)


Q: What is the main difference between Трибестан and other similar supplements or medicines for this purpose?

A: Official product information describes Трибестан as a specific, standardized medicinal preparation derived from the Tribulus terrestris plant. Standardization ensures that the concentration of the active component, protodioscin, is reliably uniform. The standardization process helps define the consistency of this specific medicinal preparation.


Q: What are the most common side effects reported by people taking Трибестан?

A: According to official product information, adverse reactions are generally reported as mild and uncommon. These effects primarily involve the gastrointestinal system. Reported reactions may include stomach discomfort, cramping, and diarrhea.


Q: How quickly should someone expect to feel the effects of Трибестан?

A: Regulatory documents indicate that the typical course of use for this preparation lasts for a minimum of 90 days. This long duration suggests that the product is intended for chronic administration. This duration of use is noted in official documents regarding the prescribed course of administration.


Q: Can Трибестан be taken long-term, or should it be cycled?

A: Official use often involves defined time courses or cycles, with some applications requiring a minimum of 90 days. However, regulatory and authoritative sources note that the long-term safety of using the extract for continuous periods exceeding 90 days is not established in the available information.


Q: Does Трибестан have any known interactions with common over-the-counter pain relievers?

A: The final regulatory prescribing information for Трибестан does not explicitly list any mandatory restrictions or prohibitions related to specific drug-drug interactions. This means no formal constraints are documented regarding co-administration with common over-the-counter pain relievers.


Q: Does Трибестан interact with alcohol or caffeine?

A: Official government regulatory prescribing information for Трибестан does not include explicit statements detailing mandatory restrictions or prohibitions related to the use of alcohol or caffeine. Therefore, no formal constraints are defined by the regulatory label for these substances.


Q: Can I take Трибестан with vitamin supplements?

A: The regulatory label does not formally document any specific interaction constraints regarding the co-administration of Трибестан with vitamin supplements. Similarly, no formal constraints are defined for combining it with other herbal products.


Q: What does the official product information say about the use of Трибестан for women?

A: Official documents describe that for female patients with specific endocrine conditions, the administration follows a cyclic pattern that is synchronized with the menstrual cycle. Additionally, studies have examined the preparation's application in women experiencing symptoms of low sexual desire.


Q: What is the role of Трибестан in supporting general vitality?

A: The general purpose of the preparation is defined by its documented ability to provide a general tonic effect. This action is intended to contribute to the body’s overall physiological balance and support the functional capacity of the sexual system.


Q: What is the difference between taking Трибестан and consuming the raw plant extract?

A: Трибестан is a specific, standardized extract, ensuring a consistent and uniform concentration of active components. Conversely, authoritative sources have indicated that the consumption of the raw plant or its spine-covered fruit may be associated with serious adverse reactions and is considered unsafe.


Q: Are the effects of Трибестан permanent after stopping its use?

A: Available research exploring the preparation’s effects typically involves studies focused on short-term symptom changes, with follow-up durations limited to around four months. Consequently, official information indicates there is limited evidence regarding the long-term stability of the observed effects after use has stopped.


Q: Is there a specific time of day recommended for using Трибестан?

A: Official administration instructions define the timing of the tablets as being with meals or immediately after a meal. This defines the appropriate timing throughout the day relative to food intake.


Q: Can Трибестан interact with medications used for mood or anxiety?

A: The official regulatory prescribing information for Трибестан does not include explicit statements detailing mandatory restrictions or prohibitions related to medications used for mood or anxiety. No formal interaction constraints are defined by the regulatory label for these categories.


Q: What studies exist regarding the long-term safety profile of Трибестан?

A: Available research predominantly explores short-term symptom changes, with follow-up durations generally limited to about four months. Regulatory and authoritative sources indicate that the long-term safety of using the extract for periods exceeding 90 days is not established within current documentation.


Q: How is the benefit of Трибестан typically measured in clinical studies?

A: In clinical studies, researchers typically monitor outcomes using validated functional scales, such as the IIEF for men and the FSFI for women. Additionally, scientists have monitored serum hormone levels in the studied populations to assess the preparation's physiological influence.


Q: Does Трибестан affect blood sugar levels?

A: Official safety information notes that the product may affect blood sugar control. Official information includes a formal warning regarding concurrent use with antidiabetes drugs, noting the potential for blood sugar levels to drop too low.


Q: Does Трибестан have an effect on cholesterol levels?

A: The general purpose of the preparation includes a documented ability to confer a hypolipidemic effect, which is an association with lowering blood lipids. Research has also specifically examined the preparation's potential association with outcomes related to the serum lipid profile.


Q: Does Трибестан help with energy levels or fatigue?

A: The general purpose of the preparation includes providing a general tonic effect. This effect is intended to contribute to the body’s overall physiological balance, which may be associated with feelings of general well-being and vitality.


Q: Are there different dosages available, and what do they mean?

A: The preparation is supplied as a 250 mg film-coated tablet. Doses are determined by a standardized usage pattern that may involve a total daily dose of up to 1500 mg, or a reduced maintenance dose for extended periods. The specific dose pattern is outlined in the official documentation according to the intended applications.

Advertisements

How should Трибестан be stored and disposed of?

How to Store and Dispose of Tribestan

Tribestan tablets must be stored according to regulatory requirements to ensure product stability. The required storage temperature is not to exceed 25 C.

Storage Conditions

  • Store the tablets in a dry place and maintain protection from light.
  • The medicine must be kept in its original container.
  • The product has a shelf-life of three years and must not be used after the expiration date.
  • A mandatory safety requirement is to store the medicine out of the sight and reach of children.

Disposal Instructions

  • Tribestan should not be disposed of via household waste or wastewater.
  • Unused or expired medication must be returned to a pharmacist or designated collection point for appropriate environmental handling.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Трибестан found in:

A-Z Index: